A new type of product claim is emerging in the Australian class action market; one which has been part of the US class action landscape for many years. Unlike previous product class actions where the safety of the product was
Toby Biddle (AU)
Toby is a disputes lawyer based in the insurance team in Sydney.
Toby has a general insurance practice, with a particular focus on disputes and liability risks in the life sciences and healthcare industries. He has particular experience and expertise in acting in class and individual actions arising from healthcare and pharmaceutical products, advising healthcare companies on insurance and litigation, advising on medical indemnity matters including defence of malpractice suits and government investigations, and advising general and liability insurers. He has represented clients in the High Court, NSW Supreme Court, ACT Supreme Court, South Australian Supreme Court, NSW Coroners’ Court, Western Australian Coroners Court, NSW Medical Tribunal and various other Federal and State Tribunals.
Pharma in Focus – reforming class actions for pharmaceutical claims
The issue of reforming class actions for pharmaceutical claims is highlighted in this opinion piece by Partner Toby Biddle on the Vioxx litigation.
This article was originally published by Pharma In Focus and is reproduced with permission.
Vioxx case highlights
…